Showing results (1-10 of 689) with videos related to
Sort By:
Pageof 69
Health Economics|March 13, 2026
Strategic Delay and Bargaining Over Public Insurance Coverage for Drugs in AustraliaJing Jing Li, Anthony HarrisPharmacoeconomics|November 28, 2015
What Can We Expect from Value-Based Funding of Medicines? A Retrospective StudyAnthony Harris, Jing Jing Li, Karen YongHealth Economics, Policy, and Law|August 9, 2011
Breaking up is hard to do: the economic impact of provisional funding contingent upon evidence developmentDuncan Mortimer, Jing Jing Li, Jennifer Watts, et al.JAMA|October 8, 2009
Using effectiveness and cost-effectiveness to make drug coverage decisions: a comparison of Britain, Australia, and CanadaFiona M Clement, Anthony Harris, Jing Jing Li, et al.International Journal of Health Care Finance and Economics|September 4, 2007
The organization and funding of the treatment of end-stage renal disease in AustraliaAnthony HarrisJournal of Cutaneous Pathology|October 30, 2014
Cutaneous crystal storing histiocytosis: a report of two casesJing Jing Li, Christopher HendersonExperimental Cell Research|September 11, 2012
The roles and therapeutic potentials of Ephs and ephrins in lung cancerJing-Jing Li, Dong XieBio Systems|December 4, 2022
Impact of social reward on the evolution of cooperation in voluntary prisoner's dilemmaYu'e Wu, Jing Jing LiBiochemical and Biophysical Research Communications|April 20, 2007
Cleavage of focal adhesion kinase (FAK) is essential in adipocyte differentiationJing-Jing Li, Dong XiePageof 69